Management of acute coronary syndromes

Research output: Contribution to journalArticle

Abstract

The treatment of acute coronary syndromes took a new direction a decade or more ago, when the emphasis shifted from relieving ischemic pain to relieving ischemia. Routine, formulaic use of nitroglycerine, morphine, and lidocaine is now archaic. Currently, a widening array of thrombolytic, antithrombotic, and antiplatelet agents is available. Extensive clinical trials continue to refine their use. The near future will likely witness further refinement, as well as new agents promising greater efficacy. The availability of effective treatment has created the need to quickly categorize and stratify patients in order to match specific treatment to specific syndromes.

Original languageEnglish (US)
Pages (from-to)917-922
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume164
Issue number6
StatePublished - Sep 15 2001

Fingerprint

Acute Coronary Syndrome
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Nitroglycerin
Lidocaine
Morphine
Therapeutics
Ischemia
Clinical Trials
Pain

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Management of acute coronary syndromes. / Schulman, Steven P; Fessler, Henry Eric.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 164, No. 6, 15.09.2001, p. 917-922.

Research output: Contribution to journalArticle

@article{6dcf33ec07c54088bc992c97fb6d946f,
title = "Management of acute coronary syndromes",
abstract = "The treatment of acute coronary syndromes took a new direction a decade or more ago, when the emphasis shifted from relieving ischemic pain to relieving ischemia. Routine, formulaic use of nitroglycerine, morphine, and lidocaine is now archaic. Currently, a widening array of thrombolytic, antithrombotic, and antiplatelet agents is available. Extensive clinical trials continue to refine their use. The near future will likely witness further refinement, as well as new agents promising greater efficacy. The availability of effective treatment has created the need to quickly categorize and stratify patients in order to match specific treatment to specific syndromes.",
author = "Schulman, {Steven P} and Fessler, {Henry Eric}",
year = "2001",
month = "9",
day = "15",
language = "English (US)",
volume = "164",
pages = "917--922",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Management of acute coronary syndromes

AU - Schulman, Steven P

AU - Fessler, Henry Eric

PY - 2001/9/15

Y1 - 2001/9/15

N2 - The treatment of acute coronary syndromes took a new direction a decade or more ago, when the emphasis shifted from relieving ischemic pain to relieving ischemia. Routine, formulaic use of nitroglycerine, morphine, and lidocaine is now archaic. Currently, a widening array of thrombolytic, antithrombotic, and antiplatelet agents is available. Extensive clinical trials continue to refine their use. The near future will likely witness further refinement, as well as new agents promising greater efficacy. The availability of effective treatment has created the need to quickly categorize and stratify patients in order to match specific treatment to specific syndromes.

AB - The treatment of acute coronary syndromes took a new direction a decade or more ago, when the emphasis shifted from relieving ischemic pain to relieving ischemia. Routine, formulaic use of nitroglycerine, morphine, and lidocaine is now archaic. Currently, a widening array of thrombolytic, antithrombotic, and antiplatelet agents is available. Extensive clinical trials continue to refine their use. The near future will likely witness further refinement, as well as new agents promising greater efficacy. The availability of effective treatment has created the need to quickly categorize and stratify patients in order to match specific treatment to specific syndromes.

UR - http://www.scopus.com/inward/record.url?scp=0035883737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035883737&partnerID=8YFLogxK

M3 - Article

C2 - 11587971

AN - SCOPUS:0035883737

VL - 164

SP - 917

EP - 922

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -